Patents by Inventor James B Mahony

James B Mahony has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Type III secretion injectisome proteins for treatment and prevention of chlamydial infections
    Patent number: 10835594
    Abstract: Cpn0803, CopB (Cpn0809) and CopD (Cpn0808) proteins and homologues thereof are shown to induce an immune response that is protective against a live challenge with Chlamydia. Methods and uses of Cpn0803 or fragments or epitopes thereof alone or together with CopB and/or CopD or fragments or epitopes thereof for treating or preventing chlamydial infection in a subject in need thereof are provided.
    Type: Grant
    Filed: January 16, 2015
    Date of Patent: November 17, 2020
    Assignee: McMaster University
    Inventors: James B. Mahony, David C. Bulir, Christopher B. Stone
  • TYPE III SECRETION INJECTISOME PROTEINS FOR TREATMENT AND PREVENTION OF CHLAMYDIAL INFECTIONS
    Publication number: 20160346375
    Abstract: Cpn0803, CopB (Cpn0809) and CopD (Cpn0808) proteins and homologues thereof are shown to induce an immune response that is protective against a live challenge with Chlamydia. Methods and uses of Cpn0803 or fragments or epitopes thereof alone or together with CopB and/or CopD or fragments or epitopes thereof for treating or preventing chlamydial infection in a subject in need thereof are provided.
    Type: Application
    Filed: January 16, 2015
    Publication date: December 1, 2016
    Inventors: James B. Mahony, David C. Bulir, Christopher B. Stone
  • Method, reagent and kit for genotyping of human papillomavirus
    Patent number: 6228577
    Abstract: This sequence of human papillomavirus present in a sample is determined by amplifying a portion of the L1 open reading frame of human papillomavirus genome to form L1 amplicons containing plus and minus amplified strands using MY09 and MY11 amplification primers, and then determining the positions of at least the A bases in the antisense amplicon using a consensus sequencing primer which is shifted six bases with respect to the MY09 primer (MY09-6). This primer has the sequence ARRGGAWACT GATCWARDTC (Seq. ID No. 3).
    Type: Grant
    Filed: March 28, 2000
    Date of Patent: May 8, 2001
    Assignee: Visible Genetics Inc.
    Inventors: James B Mahony, Alan W Seadler, Timothy D Kierstead, Sylvia Chong
  • Method, reagent and kit for genotyping of human papillomavirus
    Patent number: 6045993
    Abstract: The sequence of human papillomavirus present in a sample is determined by amplifying a portion of the L1 open reading frame of human papillomavirus genome to form L1 amplicons containing plus and minus amplified strands using MY09 and MY11 amplification primers, and then determining the positions of at least the A bases in the antisense amplicon using a consensus sequencing primer which is shifted six bases with respect to the MY09 primer (MY09-6). This primer has the sequence ARRGGAWACT GATCWARDTC (Seq. ID No.
    Type: Grant
    Filed: May 30, 1998
    Date of Patent: April 4, 2000
    Assignee: Visible Genetics Inc.
    Inventors: James B Mahony, Alan W Seadler, Timothy D Kierstead, Sylvia Chong